Imricor Medical Systems gains on premium placement to fund clinical processes
18/07/2023 05:51
** Shares of Australia-based Imricor Medical Systems Inc
IMR.AX rise as much as 5.3% to A$0.395
** Medical devices maker says raised $1 million from a
Delaware-based investor, HR Global Investments, via a private
placement at A$0.51 per share to fund clinical, regulatory
processes
** Issue price represents a premium of 36% to IMR's last
close on July 17
** Stock has risen 2.7% this year, as of last close
(Reporting by Jaskiran Singh in Bengaluru)
((Jaskiran.Singh@thomsonreuters.com;))
Recent news on Imricor Medical Systems
See all newsBrief: Imricor Medical Systems Says FDA Completes Review Of Imricor's Third PMA Module
Brief: Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module
Brief: Imricor Medical Systems Says Anticipated FDA Clearances Of Additional Capital Equipment Expected To Broaden Product Offering Available To U.S. Customers
Imricor Medical Systems hits 3-month high on securing first US hospital customer
Brief: Imricor Medical Systems, Receives FDA 510(K) Clearance For Northstar Pediatric Label Expansion